These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 19165437

  • 21. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L, Filipova S, Martos R.
    Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
    [Abstract] [Full Text] [Related]

  • 22. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC, Reil GH, Böhm M.
    Trends Cardiovasc Med; 2009 Jul; 19(5):152-7. PubMed ID: 20005474
    [Abstract] [Full Text] [Related]

  • 23. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N.
    Therapie; 2009 Jul; 64(2):111-4. PubMed ID: 19664404
    [Abstract] [Full Text] [Related]

  • 24. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A, de Silva R.
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [Abstract] [Full Text] [Related]

  • 25. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E, Bonadei I, D'Aloia A, Del Magro F, Piovanelli B, Bontempi L, Curnis A, Dei Cas L.
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [Abstract] [Full Text] [Related]

  • 26. [Ivabradine -- a novel approach for heart rate lowering].
    Er F, Hoppe UC.
    Dtsch Med Wochenschr; 2005 Jun 17; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract] [Full Text] [Related]

  • 27. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M, Talajic M, Robertson M, Tardif JC, Ferrari R, Ford I, Steg PG, Fox K, BEAUTIFUL Investigators.
    Am J Cardiol; 2011 Mar 15; 107(6):805-11. PubMed ID: 21247517
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC, Carbajal EV.
    Am J Med; 2011 Aug 15; 124(8):681-8. PubMed ID: 21787900
    [Abstract] [Full Text] [Related]

  • 37. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C, Iellamo F, Volterrani M, Lombardi M, Fini M, Banach M, Rosano GM.
    Angiology; 2010 Nov 15; 61(8):763-7. PubMed ID: 20462892
    [Abstract] [Full Text] [Related]

  • 38. [Combination of anti-angina drugs].
    Silber S.
    Z Kardiol; 1989 Nov 15; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [Abstract] [Full Text] [Related]

  • 39. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
    Fox K.
    Expert Opin Pharmacother; 2006 Jun 15; 7(9):1211-20. PubMed ID: 16732707
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.